the402 x402 endpoint directory

Wolfe 2005 Patient Activity Scale (PAS): (haq * 3.33 + pain_vas + patient_global_vas) / 3. HAQ 0-3 (not HAQ-II); pain

Mumtaz 2019 integer score for 30-day all-cause readmission after decompensated-cirrhosis index admission. Age, payer,

Álvarez-Twose 2012 REMA: male +1, female −1; serum baseline tryptase <15 μg/L −1, 15–25 0, >25 +2; pruritus, hives or

Stewart 1999 MIDAS from five caller-assigned 3-month day counts: missed paid work/school, work/school ≥50% reduced, mi

Busto 1989 CIWA-B: twenty caller-assigned 0-4 items summed (max 80). Optional hours of sleep and minutes to fall aslee

Hevesi 2019 Recurrent Instability of the Patella (RIP) after first-time dislocation. Age <25 scores 2; skeletal immatu

Bang 2009 Table 2 development screening score for undiagnosed diabetes. Age (<40 → 0, 40–49 → 1, 50–59 → 2, ≥60 → 3);

Mekhail 2005 Motzer extension: KPS <80, LDH >1.5x ULN, hemoglobin <LLN, corrected calcium >10 mg/dL, prior radiotherap

Bishop 1964 pelvic score: sum of five caller-assigned integers (dilation 0-3, effacement 0-3, station 0-3, consistency

Malcovati 2007 WPSS for MDS: WHO category (RA/RARS/5q- 0, RCMD/RCMD-RS 1, RAEB-1 2, RAEB-2 3), IPSS karyotype (good 0,

Fardet 2014 HScore (Table 4; max 337) from nine caller-assigned items: immunosuppression 18, temperature 0/33/49, orga

Iba 2017 SIC (Table 3; max 6). platelets_10e9_l >=150=0, <150 and >=100=1, <100=2. inr <=1.2=0, >1.2 and <=1.4=1, >1.4

Lansky 1987 Play-Performance Scale: caller-assigned integer 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 from parent-

Cerny 1987 Manchester score for small-cell lung cancer: LDH above laboratory ULN, sodium <132 mmol/L, ALP >1.5×ULN, bi

Karnofsky 1949 Performance Status: caller-assigned integer 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 (normal; minor s

WHO 2016 polycythemia vera criteria (Arber 2016). Met when all three majors hold, or when major 1 and major 2 hold wit

Guglielmelli 2018 MIPSS70 for transplant-age PMF: Hb <10 g/dL (1), leukocytes >25×10^9/L (2), platelets <100×10^9/L (2

Passamonti 2017 MYSEC-PM for post-PV and post-ET myelofibrosis. Score = 0.15*age + hemoglobin <11 g/dL (2) + circulati

Tefferi 2018 GIPSS for primary myelofibrosis: karyotype (favorable 0, unfavorable 1, VHR 2; caller assigns the three-t

Passamonti 2010 DIPSS for primary myelofibrosis: age >65 (1), WBC >25×10^9/L (1), hemoglobin <10 g/dL (2), peripheral-

Greenberg 2012 IPSS-R for MDS: cytogenetics (very_good 0, good 1, intermediate 2, poor 3, very_poor 4; caller assigns

Duval 2010 AML Table 5 (not ALL): PIF or CR1 >6 mo 0 / CR1 <6 mo 1; ECOG/SWOG cyto good/intermediate 0, poor 1; HLA si

Sorror 2005 HCT-specific comorbidity index. Seventeen caller-assigned comorbidities with published weights 1, 2, or 3

Rai 1975 original CLL staging (stages 0-IV). Returns rai_stage 0-4 from caller-assigned lymphadenopathy, hepatosplenom

Binet 1981 CLL staging. Stage C if anemia (Hb <10 g/dL) or thrombocytopenia (platelets <100×10^9/L), regardless of lym

Condoluci 2020 IPS-E for asymptomatic early-stage chronic lymphocytic leukemia: unmutated IGHV 1, ALC >15 ×10^9/L 1, p

CLL-IPI 2016 for chronic lymphocytic leukaemia: TP53 abnormality (del(17p) and/or TP53 mutation) 4, unmutated IGHV 2,

Hoster 2008 simplified MIPI for advanced-stage mantle cell lymphoma: age (<50 0, 50–59 1, 60–69 2, ≥70 3), ECOG (0–1 0

Thieblemont 2017 MALT-IPI (IELSG-19): age ≥70, Ann Arbor III or IV, LDH > ULN; 1 point each, max 3. Low 0, intermediat

Zhou 2014 NCCN-IPI for DLBCL in the rituximab era: age (≤40 0, 41–60 1, 61–75 2, ≥76 3), LDH/ULN (≤1 0, >1–3 1, >3 2),

Schmitz 2016 CNS-IPI: Shipp IPI factors (age >60, ECOG ≥2, LDH > ULN, Ann Arbor III or IV, extranodal sites >1) plus k

Titulaer 2011 DELTA-P for SCLC association in Lambert-Eaton myasthenic syndrome. One point each, at or within 3 months

Hoddes 1973 Stanford Sleepiness Scale degree 1-7 as assigned by the caller. Returns the degree, score (same as the deg

HAT (Lou 2008 Neurology) for sICH after stroke thrombolysis. Diabetes or glucose >200 mg/dL (1; not additive). NIHSS <

SEDAN (Strbian 2012 Ann Neurol) for sICH after stroke thrombolysis. Glucose 8.1-12.0 mmol/L (1) or >12.0 (2); early in

DRAGON (Strbian 2012 Neurology) for 3-month outcome after IV thrombolysis. CT hyperdense artery or early infarct 0/1/2

Payen 2001 Behavioral Pain Scale from three caller-assigned 1-4 items (facial_expression, upper_limbs, ventilator_comp

Gélinas 2006 CPOT from four caller-assigned 0-2 items (facial_expression, body_movements, muscle_tension, plus ventila

Merkel 1997 FLACC from five caller-assigned 0-2 items (face, legs, activity, cry, consolability) using that paper's 0/

Warden 2003 PAINAD from five caller-assigned 0-2 items (breathing, negative_vocalization, facial_expression, body_lang

AMT-10 (Hodkinson 1972): ten caller-assigned correct/incorrect flags. Each correct item scores 1; max 10. Score is the

AMT-4 (Swain 1997): four caller-assigned flags for age, date of birth, place, and year. Each correct item scores 1; ma

Douglas 2013 AWOL: four caller-assigned yes/no flags (age ≥80, unable to spell WORLD backward, not fully oriented to p

Struck 2017 2HELPS2B: BIRDs 2 points; LPD or LRDA or BIPD, prior seizure, sporadic epileptiform discharges, frequency

Ntaios 2012 ASTRAL integer score for 3-month mRS >2 in acute ischemic stroke. Age 1/5 years + NIHSS (caller 0-42) + 2

PLAN score (O'Donnell 2012 Arch Intern Med Table 4): preadmission dependence 1.5, cancer 1.5, CHF 1, atrial fibrillati

Graham 2006 CTS-6 from six caller-assigned booleans with published discrete weights (median-territory numbness 3.5, no

PASCAL (PFO-Associated Stroke Causal Likelihood; Kent 2021 JAMA Table 1) from a caller-assigned RoPE total (0-10; mage

ESUS (Hart 2014). True iff all five caller-assigned flags hold: non-lacunar infarct on CT/MRI; no ≥50% stenosis supply

Goetz 2004 modified Hoehn and Yahr stage (Table 1). Caller-assigned tokens 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, or 5.0 with t